Global and Japan Immunoglobulin G Antibody Therapeutics Market Size, Status and Forecast 2024-2031

Report ID: 1024902 | Published Date: Jan 2025 | No. of Page: 109 | Base Year: 2024 | Rating: 4.8 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Immunoglobulin G Antibody Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 IgG1
        1.2.3 IgG4
        1.2.4 Others
    1.3 Market by Application
        1.3.1 Global Immunoglobulin G Antibody Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Autoimmune
        1.3.3 Tumor
        1.3.4 Others
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Immunoglobulin G Antibody Therapeutics Market Perspective (2016-2027)
    2.2 Immunoglobulin G Antibody Therapeutics Growth Trends by Regions
        2.2.1 Immunoglobulin G Antibody Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Immunoglobulin G Antibody Therapeutics Historic Market Share by Regions (2016-2021)
        2.2.3 Immunoglobulin G Antibody Therapeutics Forecasted Market Size by Regions (2022-2027)
    2.3 Immunoglobulin G Antibody Therapeutics Industry Dynamic
        2.3.1 Immunoglobulin G Antibody Therapeutics Market Trends
        2.3.2 Immunoglobulin G Antibody Therapeutics Market Drivers
        2.3.3 Immunoglobulin G Antibody Therapeutics Market Challenges
        2.3.4 Immunoglobulin G Antibody Therapeutics Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Immunoglobulin G Antibody Therapeutics Players by Revenue
        3.1.1 Global Top Immunoglobulin G Antibody Therapeutics Players by Revenue (2016-2021)
        3.1.2 Global Immunoglobulin G Antibody Therapeutics Revenue Market Share by Players (2016-2021)
    3.2 Global Immunoglobulin G Antibody Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Immunoglobulin G Antibody Therapeutics Revenue
    3.4 Global Immunoglobulin G Antibody Therapeutics Market Concentration Ratio
        3.4.1 Global Immunoglobulin G Antibody Therapeutics Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Immunoglobulin G Antibody Therapeutics Revenue in 2020
    3.5 Immunoglobulin G Antibody Therapeutics Key Players Head office and Area Served
    3.6 Key Players Immunoglobulin G Antibody Therapeutics Product Solution and Service
    3.7 Date of Enter into Immunoglobulin G Antibody Therapeutics Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Immunoglobulin G Antibody Therapeutics Breakdown Data by Type
    4.1 Global Immunoglobulin G Antibody Therapeutics Historic Market Size by Type (2016-2021)
    4.2 Global Immunoglobulin G Antibody Therapeutics Forecasted Market Size by Type (2022-2027)

5 Immunoglobulin G Antibody Therapeutics Breakdown Data by Application
    5.1 Global Immunoglobulin G Antibody Therapeutics Historic Market Size by Application (2016-2021)
    5.2 Global Immunoglobulin G Antibody Therapeutics Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Immunoglobulin G Antibody Therapeutics Market Size (2016-2027)
    6.2 North America Immunoglobulin G Antibody Therapeutics Market Size by Type
        6.2.1 North America Immunoglobulin G Antibody Therapeutics Market Size by Type (2016-2021)
        6.2.2 North America Immunoglobulin G Antibody Therapeutics Market Size by Type (2022-2027)
        6.2.3 North America Immunoglobulin G Antibody Therapeutics Market Size by Type (2016-2027)
    6.3 North America Immunoglobulin G Antibody Therapeutics Market Size by Application
        6.3.1 North America Immunoglobulin G Antibody Therapeutics Market Size by Application (2016-2021)
        6.3.2 North America Immunoglobulin G Antibody Therapeutics Market Size by Application (2022-2027)
        6.3.3 North America Immunoglobulin G Antibody Therapeutics Market Size by Application (2016-2027)
    6.4 North America Immunoglobulin G Antibody Therapeutics Market Size by Country
        6.4.1 North America Immunoglobulin G Antibody Therapeutics Market Size by Country (2016-2021)
        6.4.2 North America Immunoglobulin G Antibody Therapeutics Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Immunoglobulin G Antibody Therapeutics Market Size (2016-2027)
    7.2 Europe Immunoglobulin G Antibody Therapeutics Market Size by Type
        7.2.1 Europe Immunoglobulin G Antibody Therapeutics Market Size by Type (2016-2021)
        7.2.2 Europe Immunoglobulin G Antibody Therapeutics Market Size by Type (2022-2027)
        7.2.3 Europe Immunoglobulin G Antibody Therapeutics Market Size by Type (2016-2027)
    7.3 Europe Immunoglobulin G Antibody Therapeutics Market Size by Application
        7.3.1 Europe Immunoglobulin G Antibody Therapeutics Market Size by Application (2016-2021)
        7.3.2 Europe Immunoglobulin G Antibody Therapeutics Market Size by Application (2022-2027)
        7.3.3 Europe Immunoglobulin G Antibody Therapeutics Market Size by Application (2016-2027)
    7.4 Europe Immunoglobulin G Antibody Therapeutics Market Size by Country
        7.4.1 Europe Immunoglobulin G Antibody Therapeutics Market Size by Country (2016-2021)
        7.4.2 Europe Immunoglobulin G Antibody Therapeutics Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Immunoglobulin G Antibody Therapeutics Market Size (2016-2027)
    8.2 Asia-Pacific Immunoglobulin G Antibody Therapeutics Market Size by Type
        8.2.1 Asia-Pacific Immunoglobulin G Antibody Therapeutics Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Immunoglobulin G Antibody Therapeutics Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Immunoglobulin G Antibody Therapeutics Market Size by Type (2016-2027)
    8.3 Asia-Pacific Immunoglobulin G Antibody Therapeutics Market Size by Application
        8.3.1 Asia-Pacific Immunoglobulin G Antibody Therapeutics Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Immunoglobulin G Antibody Therapeutics Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Immunoglobulin G Antibody Therapeutics Market Size by Application (2016-2027)
    8.4 Asia-Pacific Immunoglobulin G Antibody Therapeutics Market Size by Region
        8.4.1 Asia-Pacific Immunoglobulin G Antibody Therapeutics Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Immunoglobulin G Antibody Therapeutics Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Immunoglobulin G Antibody Therapeutics Market Size (2016-2027)
    9.2 Latin America Immunoglobulin G Antibody Therapeutics Market Size by Type
        9.2.1 Latin America Immunoglobulin G Antibody Therapeutics Market Size by Type (2016-2021)
        9.2.2 Latin America Immunoglobulin G Antibody Therapeutics Market Size by Type (2022-2027)
        9.2.3 Latin America Immunoglobulin G Antibody Therapeutics Market Size by Type (2016-2027)
    9.3 Latin America Immunoglobulin G Antibody Therapeutics Market Size by Application
        9.3.1 Latin America Immunoglobulin G Antibody Therapeutics Market Size by Application (2016-2021)
        9.3.2 Latin America Immunoglobulin G Antibody Therapeutics Market Size by Application (2022-2027)
        9.3.3 Latin America Immunoglobulin G Antibody Therapeutics Market Size by Application (2016-2027)
    9.4 Latin America Immunoglobulin G Antibody Therapeutics Market Size by Country
        9.4.1 Latin America Immunoglobulin G Antibody Therapeutics Market Size by Country (2016-2021)
        9.4.2 Latin America Immunoglobulin G Antibody Therapeutics Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Immunoglobulin G Antibody Therapeutics Market Size (2016-2027)
    10.2 Middle East & Africa Immunoglobulin G Antibody Therapeutics Market Size by Type
        10.2.1 Middle East & Africa Immunoglobulin G Antibody Therapeutics Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Immunoglobulin G Antibody Therapeutics Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Immunoglobulin G Antibody Therapeutics Market Size by Type (2016-2027)
    10.3 Middle East & Africa Immunoglobulin G Antibody Therapeutics Market Size by Application
        10.3.1 Middle East & Africa Immunoglobulin G Antibody Therapeutics Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Immunoglobulin G Antibody Therapeutics Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Immunoglobulin G Antibody Therapeutics Market Size by Application (2016-2027)
    10.4 Middle East & Africa Immunoglobulin G Antibody Therapeutics Market Size by Country
        10.4.1 Middle East & Africa Immunoglobulin G Antibody Therapeutics Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Immunoglobulin G Antibody Therapeutics Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 Roche
        11.1.1 Roche Company Details
        11.1.2 Roche Business Overview
        11.1.3 Roche Immunoglobulin G Antibody Therapeutics Introduction
        11.1.4 Roche Revenue in Immunoglobulin G Antibody Therapeutics Business (2016-2021)
        11.1.5 Roche Recent Development
    11.2 Abbvie
        11.2.1 Abbvie Company Details
        11.2.2 Abbvie Business Overview
        11.2.3 Abbvie Immunoglobulin G Antibody Therapeutics Introduction
        11.2.4 Abbvie Revenue in Immunoglobulin G Antibody Therapeutics Business (2016-2021)
        11.2.5 Abbvie Recent Development
    11.3 J & J
        11.3.1 J & J Company Details
        11.3.2 J & J Business Overview
        11.3.3 J & J Immunoglobulin G Antibody Therapeutics Introduction
        11.3.4 J & J Revenue in Immunoglobulin G Antibody Therapeutics Business (2016-2021)
        11.3.5 J & J Recent Development
    11.4 Bristol-Myers Squibb
        11.4.1 Bristol-Myers Squibb Company Details
        11.4.2 Bristol-Myers Squibb Business Overview
        11.4.3 Bristol-Myers Squibb Immunoglobulin G Antibody Therapeutics Introduction
        11.4.4 Bristol-Myers Squibb Revenue in Immunoglobulin G Antibody Therapeutics Business (2016-2021)
        11.4.5 Bristol-Myers Squibb Recent Development
    11.5 Novartis
        11.5.1 Novartis Company Details
        11.5.2 Novartis Business Overview
        11.5.3 Novartis Immunoglobulin G Antibody Therapeutics Introduction
        11.5.4 Novartis Revenue in Immunoglobulin G Antibody Therapeutics Business (2016-2021)
        11.5.5 Novartis Recent Development
    11.6 Merck
        11.6.1 Merck Company Details
        11.6.2 Merck Business Overview
        11.6.3 Merck Immunoglobulin G Antibody Therapeutics Introduction
        11.6.4 Merck Revenue in Immunoglobulin G Antibody Therapeutics Business (2016-2021)
        11.6.5 Merck Recent Development
    11.7 Alexion Pharmaceuticals
        11.7.1 Alexion Pharmaceuticals Company Details
        11.7.2 Alexion Pharmaceuticals Business Overview
        11.7.3 Alexion Pharmaceuticals Immunoglobulin G Antibody Therapeutics Introduction
        11.7.4 Alexion Pharmaceuticals Revenue in Immunoglobulin G Antibody Therapeutics Business (2016-2021)
        11.7.5 Alexion Pharmaceuticals Recent Development
    11.8 Takeda
        11.8.1 Takeda Company Details
        11.8.2 Takeda Business Overview
        11.8.3 Takeda Immunoglobulin G Antibody Therapeutics Introduction
        11.8.4 Takeda Revenue in Immunoglobulin G Antibody Therapeutics Business (2016-2021)
        11.8.5 Takeda Recent Development
    11.9 Amgen
        11.9.1 Amgen Company Details
        11.9.2 Amgen Business Overview
        11.9.3 Amgen Immunoglobulin G Antibody Therapeutics Introduction
        11.9.4 Amgen Revenue in Immunoglobulin G Antibody Therapeutics Business (2016-2021)
        11.9.5 Amgen Recent Development
    11.10 Biogen
        11.10.1 Biogen Company Details
        11.10.2 Biogen Business Overview
        11.10.3 Biogen Immunoglobulin G Antibody Therapeutics Introduction
        11.10.4 Biogen Revenue in Immunoglobulin G Antibody Therapeutics Business (2016-2021)
        11.10.5 Biogen Recent Development
    11.11 UCB
        11.11.1 UCB Company Details
        11.11.2 UCB Business Overview
        11.11.3 UCB Immunoglobulin G Antibody Therapeutics Introduction
        11.11.4 UCB Revenue in Immunoglobulin G Antibody Therapeutics Business (2016-2021)
        11.11.5 UCB Recent Development
    11.12 Eli Lilly and Company
        11.12.1 Eli Lilly and Company Company Details
        11.12.2 Eli Lilly and Company Business Overview
        11.12.3 Eli Lilly and Company Immunoglobulin G Antibody Therapeutics Introduction
        11.12.4 Eli Lilly and Company Revenue in Immunoglobulin G Antibody Therapeutics Business (2016-2021)
        11.12.5 Eli Lilly and Company Recent Development
    11.13 AstraZeneca
        11.13.1 AstraZeneca Company Details
        11.13.2 AstraZeneca Business Overview
        11.13.3 AstraZeneca Immunoglobulin G Antibody Therapeutics Introduction
        11.13.4 AstraZeneca Revenue in Immunoglobulin G Antibody Therapeutics Business (2016-2021)
        11.13.5 AstraZeneca Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Immunoglobulin G Antibody Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of IgG1
    Table 3. Key Players of IgG4
    Table 4. Key Players of Others
    Table 5. Global Immunoglobulin G Antibody Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 6. Global Immunoglobulin G Antibody Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 7. Global Immunoglobulin G Antibody Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
    Table 8. Global Immunoglobulin G Antibody Therapeutics Market Share by Regions (2016-2021)
    Table 9. Global Immunoglobulin G Antibody Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 10. Global Immunoglobulin G Antibody Therapeutics Market Share by Regions (2022-2027)
    Table 11. Immunoglobulin G Antibody Therapeutics Market Trends
    Table 12. Immunoglobulin G Antibody Therapeutics Market Drivers
    Table 13. Immunoglobulin G Antibody Therapeutics Market Challenges
    Table 14. Immunoglobulin G Antibody Therapeutics Market Restraints
    Table 15. Global Immunoglobulin G Antibody Therapeutics Revenue by Players (2016-2021) & (US$ Million)
    Table 16. Global Immunoglobulin G Antibody Therapeutics Market Share by Players (2016-2021)
    Table 17. Global Top Immunoglobulin G Antibody Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Immunoglobulin G Antibody Therapeutics as of 2020)
    Table 18. Ranking of Global Top Immunoglobulin G Antibody Therapeutics Companies by Revenue (US$ Million) in 2020
    Table 19. Global 5 Largest Players Market Share by Immunoglobulin G Antibody Therapeutics Revenue (CR5 and HHI) & (2016-2021)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Immunoglobulin G Antibody Therapeutics Product Solution and Service
    Table 22. Date of Enter into Immunoglobulin G Antibody Therapeutics Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Immunoglobulin G Antibody Therapeutics Market Size by Type (2016-2021) (US$ Million)
    Table 25. Global Immunoglobulin G Antibody Therapeutics Revenue Market Share by Type (2016-2021)
    Table 26. Global Immunoglobulin G Antibody Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 27. Global Immunoglobulin G Antibody Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 28. Global Immunoglobulin G Antibody Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
    Table 29. Global Immunoglobulin G Antibody Therapeutics Revenue Market Share by Application (2016-2021)
    Table 30. Global Immunoglobulin G Antibody Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 31. Global Immunoglobulin G Antibody Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 32. North America Immunoglobulin G Antibody Therapeutics Market Size by Type (2016-2021) (US$ Million)
    Table 33. North America Immunoglobulin G Antibody Therapeutics Market Size by Type (2022-2027) & (US$ Million)
    Table 34. North America Immunoglobulin G Antibody Therapeutics Market Size by Application (2016-2021) (US$ Million)
    Table 35. North America Immunoglobulin G Antibody Therapeutics Market Size by Application (2022-2027) & (US$ Million)
    Table 36. North America Immunoglobulin G Antibody Therapeutics Market Size by Country (2016-2021) & (US$ Million) 
    Table 37. North America Immunoglobulin G Antibody Therapeutics Market Size by Country (2022-2027) & (US$ Million) 
    Table 38. Europe Immunoglobulin G Antibody Therapeutics Market Size by Type (2016-2021) (US$ Million)
    Table 39. Europe Immunoglobulin G Antibody Therapeutics Market Size by Type (2022-2027) & (US$ Million)
    Table 40. Europe Immunoglobulin G Antibody Therapeutics Market Size by Application (2016-2021) (US$ Million)
    Table 41. Europe Immunoglobulin G Antibody Therapeutics Market Size by Application (2022-2027) & (US$ Million)
    Table 42. Europe Immunoglobulin G Antibody Therapeutics Market Size by Country (2016-2021) & (US$ Million) 
    Table 43. Europe Immunoglobulin G Antibody Therapeutics Market Size by Country (2022-2027) & (US$ Million) 
    Table 44. Asia-Pacific Immunoglobulin G Antibody Therapeutics Market Size by Type (2016-2021) (US$ Million)
    Table 45. Asia-Pacific Immunoglobulin G Antibody Therapeutics Market Size by Type (2022-2027) & (US$ Million)
    Table 46. Asia-Pacific Immunoglobulin G Antibody Therapeutics Market Size by Application (2016-2021) (US$ Million)
    Table 47. Asia-Pacific Immunoglobulin G Antibody Therapeutics Market Size by Application (2022-2027) & (US$ Million)
    Table 48. Asia-Pacific Immunoglobulin G Antibody Therapeutics Market Size by Region (2016-2021) & (US$ Million) 
    Table 49. Asia-Pacific Immunoglobulin G Antibody Therapeutics Market Size by Region (2022-2027) & (US$ Million) 
    Table 50. Latin America Immunoglobulin G Antibody Therapeutics Market Size by Type (2016-2021) (US$ Million)
    Table 51. Latin America Immunoglobulin G Antibody Therapeutics Market Size by Type (2022-2027) & (US$ Million)
    Table 52. Latin America Immunoglobulin G Antibody Therapeutics Market Size by Application (2016-2021) (US$ Million)
    Table 53. Latin America Immunoglobulin G Antibody Therapeutics Market Size by Application (2022-2027) & (US$ Million)
    Table 54. Latin America Immunoglobulin G Antibody Therapeutics Market Size by Country (2016-2021) & (US$ Million) 
    Table 55. Latin America Immunoglobulin G Antibody Therapeutics Market Size by Country (2022-2027) & (US$ Million) 
    Table 56. Middle East & Africa Immunoglobulin G Antibody Therapeutics Market Size by Type (2016-2021) (US$ Million)
    Table 57. Middle East & Africa Immunoglobulin G Antibody Therapeutics Market Size by Type (2022-2027) & (US$ Million)
    Table 58. Middle East & Africa Immunoglobulin G Antibody Therapeutics Market Size by Application (2016-2021) (US$ Million)
    Table 59. Middle East & Africa Immunoglobulin G Antibody Therapeutics Market Size by Application (2022-2027) & (US$ Million)
    Table 60. Middle East & Africa Immunoglobulin G Antibody Therapeutics Market Size by Country (2016-2021) & (US$ Million) 
    Table 61. Middle East & Africa Immunoglobulin G Antibody Therapeutics Market Size by Country (2022-2027) & (US$ Million) 
    Table 62. Roche Company Details
    Table 63. Roche Business Overview
    Table 64. Roche Immunoglobulin G Antibody Therapeutics Product
    Table 65. Roche Revenue in Immunoglobulin G Antibody Therapeutics Business (2016-2021) & (US$ Million)
    Table 66. Roche Recent Development
    Table 67. Abbvie Company Details
    Table 68. Abbvie Business Overview
    Table 69. Abbvie Immunoglobulin G Antibody Therapeutics Product
    Table 70. Abbvie Revenue in Immunoglobulin G Antibody Therapeutics Business (2016-2021) & (US$ Million)
    Table 71. Abbvie Recent Development
    Table 72. J & J Company Details
    Table 73. J & J Business Overview
    Table 74. J & J Immunoglobulin G Antibody Therapeutics Product
    Table 75. J & J Revenue in Immunoglobulin G Antibody Therapeutics Business (2016-2021) & (US$ Million)
    Table 76. J & J Recent Development
    Table 77. Bristol-Myers Squibb Company Details
    Table 78. Bristol-Myers Squibb Business Overview
    Table 79. Bristol-Myers Squibb Immunoglobulin G Antibody Therapeutics Product
    Table 80. Bristol-Myers Squibb Revenue in Immunoglobulin G Antibody Therapeutics Business (2016-2021) & (US$ Million)
    Table 81. Bristol-Myers Squibb Recent Development
    Table 82. Novartis Company Details
    Table 83. Novartis Business Overview
    Table 84. Novartis Immunoglobulin G Antibody Therapeutics Product
    Table 85. Novartis Revenue in Immunoglobulin G Antibody Therapeutics Business (2016-2021) & (US$ Million)
    Table 86. Novartis Recent Development
    Table 87. Merck Company Details
    Table 88. Merck Business Overview
    Table 89. Merck Immunoglobulin G Antibody Therapeutics Product
    Table 90. Merck Revenue in Immunoglobulin G Antibody Therapeutics Business (2016-2021) & (US$ Million)
    Table 91. Merck Recent Development
    Table 92. Alexion Pharmaceuticals Company Details
    Table 93. Alexion Pharmaceuticals Business Overview
    Table 94. Alexion Pharmaceuticals Immunoglobulin G Antibody Therapeutics Product
    Table 95. Alexion Pharmaceuticals Revenue in Immunoglobulin G Antibody Therapeutics Business (2016-2021) & (US$ Million)
    Table 96. Alexion Pharmaceuticals Recent Development
    Table 97. Takeda Company Details
    Table 98. Takeda Business Overview
    Table 99. Takeda Revenue in Immunoglobulin G Antibody Therapeutics Business (2016-2021) & (US$ Million)
    Table 100. Takeda Recent Development
    Table 101. Amgen Company Details
    Table 102. Amgen Business Overview
    Table 103. Amgen Immunoglobulin G Antibody Therapeutics Product
    Table 104. Amgen Revenue in Immunoglobulin G Antibody Therapeutics Business (2016-2021) & (US$ Million)
    Table 105. Amgen Recent Development
    Table 106. Biogen Company Details
    Table 107. Biogen Business Overview
    Table 108. Biogen Immunoglobulin G Antibody Therapeutics Product
    Table 109. Biogen Revenue in Immunoglobulin G Antibody Therapeutics Business (2016-2021) & (US$ Million)
    Table 110. Biogen Recent Development
    Table 111. UCB Company Details
    Table 112. UCB Business Overview
    Table 113. UCB Immunoglobulin G Antibody Therapeutics Product
    Table 114. UCB Revenue in Immunoglobulin G Antibody Therapeutics Business (2016-2021) & (US$ Million)
    Table 115. UCB Recent Development
    Table 116. Eli Lilly and Company Company Details
    Table 117. Eli Lilly and Company Business Overview
    Table 118. Eli Lilly and Company Immunoglobulin G Antibody Therapeutics Product
    Table 119. Eli Lilly and Company Revenue in Immunoglobulin G Antibody Therapeutics Business (2016-2021) & (US$ Million)
    Table 120. Eli Lilly and Company Recent Development
    Table 121. AstraZeneca Company Details
    Table 122. AstraZeneca Business Overview
    Table 123. AstraZeneca Immunoglobulin G Antibody Therapeutics Product
    Table 124. AstraZeneca Revenue in Immunoglobulin G Antibody Therapeutics Business (2016-2021) & (US$ Million)
    Table 125. AstraZeneca Recent Development
    Table 126. Research Programs/Design for This Report
    Table 127. Key Data Information from Secondary Sources
    Table 128. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Immunoglobulin G Antibody Therapeutics Market Share by Type: 2020 VS 2027
    Figure 2. IgG1 Features
    Figure 3. IgG4 Features
    Figure 4. Others Features
    Figure 5. Global Immunoglobulin G Antibody Therapeutics Market Share by Application: 2020 VS 2027
    Figure 6. Autoimmune Case Studies
    Figure 7. Tumor Case Studies
    Figure 8. Others Case Studies
    Figure 9. Immunoglobulin G Antibody Therapeutics Report Years Considered
    Figure 10. Global Immunoglobulin G Antibody Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 11. Global Immunoglobulin G Antibody Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 12. Global Immunoglobulin G Antibody Therapeutics Market Share by Regions: 2020 VS 2027
    Figure 13. Global Immunoglobulin G Antibody Therapeutics Market Share by Regions (2022-2027)
    Figure 14. Global Immunoglobulin G Antibody Therapeutics Market Share by Players in 2020
    Figure 15. Global Top Immunoglobulin G Antibody Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Immunoglobulin G Antibody Therapeutics as of 2020
    Figure 16. The Top 10 and 5 Players Market Share by Immunoglobulin G Antibody Therapeutics Revenue in 2020
    Figure 17. Global Immunoglobulin G Antibody Therapeutics Revenue Market Share by Type (2016-2021)
    Figure 18. Global Immunoglobulin G Antibody Therapeutics Revenue Market Share by Type (2022-2027)
    Figure 19. North America Immunoglobulin G Antibody Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 20. North America Immunoglobulin G Antibody Therapeutics Market Share by Type (2016-2027)
    Figure 21. North America Immunoglobulin G Antibody Therapeutics Market Share by Application (2016-2027)
    Figure 22. North America Immunoglobulin G Antibody Therapeutics Market Share by Country (2016-2027)
    Figure 23. United States Immunoglobulin G Antibody Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 24. Canada Immunoglobulin G Antibody Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 25. Europe Immunoglobulin G Antibody Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 26. Europe Immunoglobulin G Antibody Therapeutics Market Share by Type (2016-2027)
    Figure 27. Europe Immunoglobulin G Antibody Therapeutics Market Share by Application (2016-2027)
    Figure 28. Europe Immunoglobulin G Antibody Therapeutics Market Share by Country (2016-2027)
    Figure 29. Germany Immunoglobulin G Antibody Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 30. France Immunoglobulin G Antibody Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 31. U.K. Immunoglobulin G Antibody Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. Italy Immunoglobulin G Antibody Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. Russia Immunoglobulin G Antibody Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Nordic Immunoglobulin G Antibody Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Asia-Pacific Immunoglobulin G Antibody Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 36. Asia-Pacific Immunoglobulin G Antibody Therapeutics Market Share by Type (2016-2027)
    Figure 37. Asia-Pacific Immunoglobulin G Antibody Therapeutics Market Share by Application (2016-2027)
    Figure 38. Asia-Pacific Immunoglobulin G Antibody Therapeutics Market Share by Region (2016-2027)
    Figure 39. China Immunoglobulin G Antibody Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 40. Japan Immunoglobulin G Antibody Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 41. South Korea Immunoglobulin G Antibody Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. Southeast Asia Immunoglobulin G Antibody Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. India Immunoglobulin G Antibody Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. Australia Immunoglobulin G Antibody Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. Latin America Immunoglobulin G Antibody Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 46. Latin America Immunoglobulin G Antibody Therapeutics Market Share by Type (2016-2027)
    Figure 47. Latin America Immunoglobulin G Antibody Therapeutics Market Share by Application (2016-2027)
    Figure 48. Latin America Immunoglobulin G Antibody Therapeutics Market Share by Country (2016-2027)
    Figure 49. Mexico Immunoglobulin G Antibody Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 50. Brazil Immunoglobulin G Antibody Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 51. Middle East & Africa Immunoglobulin G Antibody Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 52. Middle East & Africa Immunoglobulin G Antibody Therapeutics Market Share by Type (2016-2027)
    Figure 53. Middle East & Africa Immunoglobulin G Antibody Therapeutics Market Share by Application (2016-2027)
    Figure 54. Middle East & Africa Immunoglobulin G Antibody Therapeutics Market Share by Country (2016-2027)
    Figure 55. Turkey Immunoglobulin G Antibody Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 56. Saudi Arabia Immunoglobulin G Antibody Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 57. UAE Immunoglobulin G Antibody Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 58. Roche Revenue Growth Rate in Immunoglobulin G Antibody Therapeutics Business (2016-2021)
    Figure 59. Abbvie Revenue Growth Rate in Immunoglobulin G Antibody Therapeutics Business (2016-2021)
    Figure 60. J & J Revenue Growth Rate in Immunoglobulin G Antibody Therapeutics Business (2016-2021)
    Figure 61. Bristol-Myers Squibb Revenue Growth Rate in Immunoglobulin G Antibody Therapeutics Business (2016-2021)
    Figure 62. Novartis Revenue Growth Rate in Immunoglobulin G Antibody Therapeutics Business (2016-2021)
    Figure 63. Merck Revenue Growth Rate in Immunoglobulin G Antibody Therapeutics Business (2016-2021)
    Figure 64. Alexion Pharmaceuticals Revenue Growth Rate in Immunoglobulin G Antibody Therapeutics Business (2016-2021)
    Figure 65. Takeda Revenue Growth Rate in Immunoglobulin G Antibody Therapeutics Business (2016-2021)
    Figure 66. Amgen Revenue Growth Rate in Immunoglobulin G Antibody Therapeutics Business (2016-2021)
    Figure 67. Biogen Revenue Growth Rate in Immunoglobulin G Antibody Therapeutics Business (2016-2021)
    Figure 68. UCB Revenue Growth Rate in Immunoglobulin G Antibody Therapeutics Business (2016-2021)
    Figure 69. Eli Lilly and Company Revenue Growth Rate in Immunoglobulin G Antibody Therapeutics Business (2016-2021)
    Figure 70. AstraZeneca Revenue Growth Rate in Immunoglobulin G Antibody Therapeutics Business (2016-2021)
    Figure 71. Bottom-up and Top-down Approaches for This Report
    Figure 72. Data Triangulation
    Figure 73. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Roche
Abbvie
J & J
Bristol-Myers Squibb
Novartis
Merck
Alexion Pharmaceuticals
Takeda
Amgen
Biogen
UCB
Eli Lilly and Company
AstraZeneca
Frequently Asked Questions
Immunoglobulin G Antibody Therapeutics report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Immunoglobulin G Antibody Therapeutics report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Immunoglobulin G Antibody Therapeutics report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Autoantibody Kit

Autoantibody Kit market is segmented by region (country), players, by Type, and by Application. P ... Read More